Published in
American Association for the Advancement of Science, Science Translational Medicine, 609(13), 2021
DOI: 10.1126/scitranslmed.abj0847
Links
Tools
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Journal article published in 2021 by
Richard A. Urbanowicz 
,
Theocharis Tsoleridis ,
Hannah J. Jackson ,
Lola Cusin ,
Joshua D. Duncan ,
Joseph G. Chappell ,
Alexander W. Tarr ,
Jessica Nightingale,
Alan R. Norrish ,
Adeel Ikram ,
Ben Marson ,
Simon J. Craxford,
Anthony Kelly ,
Guruprasad P. Aithal ,
Amrita Vijay
and other authors.
,
Theocharis Tsoleridis ,
Hannah J. Jackson ,
Lola Cusin ,
Joshua D. Duncan ,
Joseph G. Chappell ,
Alexander W. Tarr ,
Jessica Nightingale,
Alan R. Norrish ,
Adeel Ikram ,
Ben Marson ,
Simon J. Craxford,
Anthony Kelly ,
Guruprasad P. Aithal ,
Amrita Vijay
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Antibody responses to SARS-CoV-2 variants increase after two doses of BNT162b2 vaccine in both previously infected and naïve individuals.